pulmonary inf./TB/sarcoidosis Flashcards

1
Q

questions to ask

A

sick contacts

travel hx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

testing to do

A

CXR
sputum sample (40% can’t)
-may need bronchoscopy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

sodium levels may be

A

low

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

CAP org

A

Strep pneumo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

cough mechanism prevents

A

URI from becoming LRTI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

S. pneumo presentation

A
fever, hypothermia, tachypnea, cough +/- sputum (typically), dyspnea, chills/rigors/sweats
-ha, lack of appetite
-clammy, bluish skin
-N/V, joint pain
-fatigue
-inspiratory crackles, bronchial breath sounds
-may have hemoptysis
(non-hosp. pts, not chemo pt)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

S. pneumo CXR

A

-+ CXR w/ infiltrate or consolidation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

S. pneumo compensatory mechs

A
  • low BP

- inc. HR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

dx testing necessary?

A

not always; empirically tx for S.pneumo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

S.pneumo tx

A

augmentin, levoquin, PCN, clindamycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

other dx

A

Cx, Gs, urine antigen testing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

other orgs

A

Legionella pneumophilia
Group A, C, G strep
Staph aureus (inc. CA-MRSA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

complication with S. aureus (CA-MRSA)

A

fall months, get influenza–>secondary bac. pneumo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

consider HIV testing

A

hypoxemic, bacteremic, young, otherwise sev. pts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

HIV+ pts w/ CD4 count >200 more likely

A

to have CAP vs. OI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

flu season

A

(sept-march)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

if flu pt. 5 days oral Tamiflu again has high fevers, purulent sputum

A

S. aureus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

S. aureus tx

A

vancomycin, zyvox (linezolid)$, PCN, augmentin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

MRSA

A

bactrin, clindamycin, doxycyclin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q
  • fever 101.5
  • ha, chills, body ache, malaise
  • “foggy”
  • hyponatremic (121)
  • WBC count low (4.2K)
  • heating/cooling repair, produce section, etc
A

Legionella pneumonia

“Legionnaire’s disease”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

fogginess, altered may be due to

A

hyponatremia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Legionella on sputum Cx

A

very rarely

do urine antigen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Legionella symps begin

A

2-14 days post-exposure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Leg.: transmitted?

A

cannot be transmitted person-person

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Leg tx 1st line
macrolide(clarithromycin, azithromycin) | doxycycline
26
Leg tx rec. abx, comorb.
resp. FQs | macrolide + B lactam (cefuroxime, amoxicillin, augmentin)
27
inpt. management
resp. FQ: moxifloxacin, levofloxacin, IV moxifloxacin, levaquin* macrolide + beta lactam: azithromycin + ceftriaxone*
28
inpt ICU management
azithromycin or resp. FQ + antipneumococcal B lactam (cef, amp)
29
inpt. ICU tx for pts allergic to B lactams
FQ + aztreonam, tigecycline
30
inpt. ICU tx for high risk pseudomonas
piperacillin-tazobactam, cefepime, carbapenem, ciprofloxacine or levofloxacin -poss. B lactam + aminoglycoside (gentamicin, tobramycin, amikacin)* rarely used
31
inpt. ICU tx for high MRSA risk
influenza, DM, HAP (make sure covers pseudomonas and MRSA) add vancomycin or linezolid
32
old, bed bound, nursing home: cause of pneumonia?
aspiration on own secretions | -don't cough
33
HCAP orgs
pseudomonas, MRSA
34
HCAP risks
- Antibiotic therapy in the past 90 days - Acute hospital stay for at least 2 days in the past 90 days - Residence in an extended care facility or recent prolonged rehab stay - Need for infusion therapy (chemotherapy) or hemodialysis - Home wound care - Family member with infections involving multidrug resistant organisms - Immunosuppressed patient
35
HAP develops
>48 hrs AFTER admission to hospital
36
VAP occurs in
a mech. vent. pt >48 hrs after intubation
37
what to do with intubation pts
-keep head of bed 30 degrees -do mouth care (suction) CULTURE!
38
HAP orgs
- S. aureus (MRSA) - S. pneumo (DR) - G- orgs - ESBL prod. orgs (E. coli, Kleb, enterobacter) - resistant to PCN, cephalosporins, use carbapenems - CRE prod. orgs in enterobacter family: move to aminoglycosides (tigasil, tobramycin, etc) - acinetobacter spp. (chron. ventilated, trachs): unasyn, tigacil (otherwise resist.)
39
HAP empiric tx
S. aureus/MRSA/pseudomonas coverage - antipseudomonals (cefepime, ceftazidime, imipenem, meropenem, piperacillin-tazobactam, aztreonam) - 2nd antipseudomonal (Levofloxacin, Cipro, aminoglycoside) - MRSA coverage (Vancomycin, Linezolid, also tigacil, cefteraline?) - known ESBL carrier? (carbapenem)* right away!*
40
aminoglycoside
gentamicin tobramycin amikacin (can give inhaled gentamicin!)
41
``` 15 lb weight loss, 101 F 3 weeks gen. malaise coughing up thick green phlegm, foul smell etOH, bad teeth ```
aspirated inf. sputum-->purulence in lungs-->cough up from bronchus CXR: obvious lung abscess -weight loss from anaerobic process
42
w/ lung abscess pt.
more... may need to decorticate (keep malignancy in ddx)
43
lung abscess pt. dx
probable anaerobic pneumonia w. lung abscess
44
probable anaerobic pneumonia w. lung abscess risks
aspiration risk : etOH, nursing home -indolent symps w/ fever, weight loss MORE
45
probable anaerobic pneumonia w. lung abscess tx
clindamycin amoxicillin-clavulanate (augmentin (for anaerobes)) amoxicillin (not usually) moxifloxacin (anaer. cov) IV zosyn, IV carbapenems, IV clindamycin (for hosp. pts)
46
pulm. infiltrates in immuncomp pts
consider opportunistic orgs, viruses, protozoa, fungi | -
47
pulm infilt. in HIV pt w/. high CD4 >200 more likely to be
Strep pneumo vs. pneumocystis jiroveci or other OI
48
fungal etiology of pulm. infiltrates
aspergillus, histplasmosis, blastomycosis, coccidiodomycosis
49
reality with aspergillus
infects people who are SEVERELY immune compromised (not everyday ppl to avoid rent due to mold) - pts will dev. fungal ball (not nec. causes sickness) - causes UR allergy sympts (chronic dry cough, irritation)
50
coccidiodomycosis
valley fever
51
histplasmosis, blastomycosis
may be in immunocompetent ppl
52
viral etiologies of pulm. infiltrates
HSV, CMV pneumonia
53
other causes of pulm. infilt.
atypical mycobacterial infections (pts with sticky airways, high Ig levels, floppy airways) (40-80 yo tiny women) no good tx (Tb drugs)
54
TB stats
In 2013 a total of 9,588 new TB cases were reported in the US Incidence of 3.0 cases per 100,000 people Decrease from incidence of 4.2% in 2012 Incidence among foreign-born is 13x greater 64.6% of all TB cases Half of all cases of TB in 2013 occurred in California, Texas, New York, and Florida 4,917 total cases 86 total cases of MDR TB were identified in 2012
55
TB greatest country
MEXICO
56
+ tuberculin skin test
induration* >15 mm in gen pop >10 mm in HC workers, inc. risk >5 mm in HIV+
57
TB blood testing
INterferon Gamma Release Assay (IGRA) - QuantiFERON TB gold in-tube test (vs. T-spot TB test?) * reduces tester error, can be used on BCG vaccinated pts
58
IGRA advantages
Requires a single patient visit to draw a blood sample. Results can be available within 24 hours. Does not boost responses measured by subsequent tests, which can happen with tuberculin skin tests (TST). Is not subject to reader bias that can occur with TST. **Is not affected by prior BCG vaccination.**
59
IGRA disadvantages
Blood samples must be processed within ~24 hours after collection while white blood cells are still viable. There is limited data on the use of QFT-GIT in children younger than 17 years of age, among persons recently exposed to M. tuberculosis, and in immunocompromised patients. Errors in collecting or transporting blood specimens or in running and interpreting the assay can decrease the accuracy and potentially lead to indeterminate results. False positive results can occur with Mycobacterium szulgai, Mycobacterium kansasii, and Mycobacterium marinum.
60
if skin is - and quantiferon is +
it is POSITIVE | get CXR
61
if skin is + and quantiferon is -
interminate, consider factors (case by case) | get CXR
62
if pt. are on anti-inflammatory tx (anti-TNF)
MORE | drop chances of getting TB down to general population
63
TB seen where in lungs
top, oxygen rich, aerated
64
+ CXR
get 3 sputum samples, bronchoscopy if unable
65
if active TB
public health for MDRTB therapy
66
if 3 sputum samples neg
scarring on CXR
67
once latent TB established
discontinue tx
68
who should be tx?
everyone, esp. immuncomps, HIV+, those about to start immunosuppressive meds
69
what are risks if no LTBI tx taken?
lifetim | MORE
70
LTBI tx (6-9 mos)
isoniazid, rifampin | +follow liver function
71
this med does not play well with other
rifampin (for young ppl, not on many other meds) (used back up for BC) (fine for etOH)
72
active TB tx
RIPE: rifampin, isoniazid, pyrazinamide, ethambutol (streptomycin) *core*
73
active TB always send..
susceptibility Cx
74
1st 2 mos... | then 4 mos...
all 4 drugs | isoniazid, rifampin
75
never tx active TB with
single agent
76
isolate active causes?
no longer infectious after 2 wks tx
77
MDR-TB
resist. to INH and RIF
78
XDR-TB
less common INF, RIF, others, FQ
79
INH resistance
&&
80
Rifampin resistance
***
81
INH + Rifampin resistance
III
82
XDR-TB tx
admin 4-6 drugs in combo (*SUSCEPTIBLE*) : mult. 2nd line drugs, should include all avail. 1st line drugs - newer agents, trial agents - 18-24 mos (2 yrs!)
83
sarcoidosis CXR
bilat perihilar finding, may have parenchymal involvement
84
biopsy of hilar nodes (sarcoidosis)
``` noncaseating granulomas (excl. lymphoma) ```
85
serum ACE in sarcoid.
elevated in 40-80% pts
86
sarcoid. multisyst. presentation
skin, eye, joint involvement
87
sarcoid. tx
oral prednisone (mos-yrs)